Preventing unwanted pregnancies and protecting moms and babies since the 1980s.
- Under the MindanaoHealth project, almost 72,000 women accessed and received desired long-acting, reversible contraception in six regions of Mindanao between 2013 and 2018.
- During the same time frame in the same regions, deliveries by skilled birth attendants increased from 65% to 74%.
- MindanaoHealth project-supported Adolescent and Youth Reproductive Health facilities provided more than 45,000 adolescents and youth with reproductive health information and services.
- The National Reproductive Health/Family Planning Guidelines, which Jhpiego helped develop, are still being used by family planning providers to offer standardized services to clients across the Philippines.
Our Work in Philippines
This project, led by Oxfam Canada and funded by Global Affairs Canada, seeks to improve sexual and reproductive health and rights (SRHR) for women and girls in six underserved, conflict-affected and disadvantaged regions of Philippines. To reach this goal, the project is providing the target population with culturally- and gender-sensitive sexual and reproductive health programs and services, and improving the effectiveness of women’s rights organizations to advance SRHR and prevent gender-based violence (GBV). As a technical partner, Jhpiego is improving the capacity of the public and private health system to provide comprehensive and gender-responsive SRHR information and services. This includes: training health service providers, enhancing youth-friendly and gender-responsive health facilities to provide comprehensive SRHR services, and enhancing the management and coordination for SRHR and GBV services.
With funding from the National Institutes of Health, Jhpiego is conducting a study in the Philippines on the performance, safety and efficacy of a new cryotherapy device, called the CryoPop, for cervical dysplasia. More specifically, since existing technology is costly, the CryoPop is being tested for use in low- and middle-income countries to arrest pre-malignant lesions. In partnership with The Cancer Institute Foundation, Inc. for Moving as One, Jhpiego is: 1) assessing the performance characteristics of CryoPop compared to standard cryotherapy equipment in women with normal cervical cytology; and 2) determining the safety of CryoPop in women with abnormal cervical cytology.